Correlation Between E L and Rakovina Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both E L and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining E L and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between E L Financial Corp and Rakovina Therapeutics, you can compare the effects of market volatilities on E L and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in E L with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of E L and Rakovina Therapeutics.

Diversification Opportunities for E L and Rakovina Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between ELF and Rakovina is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding E L Financial Corp and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and E L is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on E L Financial Corp are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of E L i.e., E L and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between E L and Rakovina Therapeutics

Assuming the 90 days trading horizon E L is expected to generate 2.27 times less return on investment than Rakovina Therapeutics. But when comparing it to its historical volatility, E L Financial Corp is 6.81 times less risky than Rakovina Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Rakovina Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  16.00  in Rakovina Therapeutics on September 12, 2024 and sell it today you would lose (2.00) from holding Rakovina Therapeutics or give up 12.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

E L Financial Corp  vs.  Rakovina Therapeutics

 Performance 
       Timeline  
E L Financial 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in E L Financial Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, E L may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Rakovina Therapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

E L and Rakovina Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with E L and Rakovina Therapeutics

The main advantage of trading using opposite E L and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if E L position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.
The idea behind E L Financial Corp and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk